02:10 PM EDT, 05/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target by $8 to $238, valuing ALL shares at 13.6x our 2025 operating EPS estimate of $17.55 (raised today by $0.10) and at 11x our 2026 EPS view of $21.55 (upped today by $0.40), vs. the three-year average forward multiple of 14.3x and a peer average of 11x. Allstate ( ALL ) reported mixed Q1 results as higher catastrophe losses of $2.2B (vs. $731M) drove a combined ratio of 97.4%, though the underlying ratio improved 380 bps to 83.1%. Our view is tempered by the uncertainty surrounding the impact auto tariffs will have on auto parts, and ultimately ALL's claim costs. Shares trade at 11.5x our 2025 EPS estimate, below the three-year average of 14.3x, with a 2% dividend yield. We view the low-beta shares as undervalued given improving underlying profitability and historically attractive multiples.